Cargando…
Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment
BACKGROUND: Although patients have different treatment preferences, these individual preferences could often be grouped in subgroups with shared preferences. Knowledge of these subgroups as well as factors associated with subgroup membership supports health care professionals in the understanding of...
Autores principales: | van Heuckelum, Milou, Mathijssen, Elke GE, Vervloet, Marcia, Boonen, Annelies, Hebing, Renske CF, Pasma, Annelieke, Vonkeman, Harald E, Wenink, Mark H, van den Bemt, Bart JF, van Dijk, Liset |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660639/ https://www.ncbi.nlm.nih.gov/pubmed/31413548 http://dx.doi.org/10.2147/PPA.S204111 |
Ejemplares similares
-
A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels
por: Mathijssen, Elke GE, et al.
Publicado: (2018) -
Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence
por: van Heuckelum, M., et al.
Publicado: (2019) -
Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease
por: Pasma, Annelieke, et al.
Publicado: (2015) -
Disentangling Rheumatoid Arthritis Patients’ Implicit and Explicit Attitudes toward Methotrexate
por: Linn, Annemiek J., et al.
Publicado: (2016) -
Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis
por: Beckers, Esther, et al.
Publicado: (2023)